GERON CORP

GERN · Nasdaq · SIC 2834: Pharmaceutical Preparations
349
SEC Filings

Business Summary

PART I Company Overview We are a commercial-stage biopharmaceutical company aiming to change lives by changing the course of blood cancer. Our first-in-class telomerase inhibitor, RYTELO (imetelstat), harnesses Nobel Prize winning science in a treatment that scientific evidence suggests reduces proliferation of malignant cells, allowing production of new healthy cells, which we believe drives differentiated clinical benefits, potentially altering the underlying course and modifying the disease o...

Next Earnings

Q2 FY2026 — expected 2026-08-06

Key Facts from Earnings Calls

TypeSubjectDetailQuarter
topic_mentionGERNdiscussed_in_filing Cybersecurity
topic_mentionGERNdiscussed_in_filing Trusted Computing
topic_mentionGERNdiscussed_in_filing Blockchain & Crypto
topic_mentionGERNdiscussed_in_filing Supply Chain
topic_mentionGERNdiscussed_in_filing Regulation
topic_mentionGERNdiscussed_in_filing Healthcare & Bio
topic_mentionGERNdiscussed_in_filing Platform & Ecosystem
topic_mentionGERNdiscussed_in_filing Sovereign & Government
topic_mentionGERNdiscussed_in_filing Cybersecurity
topic_mentionGERNdiscussed_in_filing Trusted Computing
topic_mentionGERNdiscussed_in_filing Blockchain & Crypto
topic_mentionGERNdiscussed_in_filing Supply Chain
topic_mentionGERNdiscussed_in_filing Regulation
topic_mentionGERNdiscussed_in_filing Healthcare & Bio
topic_mentionGERNdiscussed_in_filing Platform & Ecosystem
topic_mentionGERNdiscussed_in_filing Sovereign & Government
topic_mentionGERNdiscussed_in_filing Cybersecurity
topic_mentionGERNdiscussed_in_filing Trusted Computing
topic_mentionGERNdiscussed_in_filing Blockchain & Crypto
topic_mentionGERNdiscussed_in_filing Supply Chain

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-03-022025-12-310000886744-26-000008EDGAR95K words
2025-02-272024-12-310000950170-25-027982EDGAR
2024-02-282023-12-310000950170-24-022056EDGAR
2023-03-162022-12-310000950170-23-008437EDGAR
2022-03-102021-12-310001564590-22-009627EDGAR
2021-03-112020-12-310001564590-21-012493EDGAR
2020-03-122019-12-310001564590-20-010449EDGAR
2019-03-072018-12-310001564590-19-006759EDGAR
2018-03-162017-12-310001564590-18-006051EDGAR
2017-03-012016-12-310001047469-17-001123EDGAR

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2025-11-072025-09-300000886744-25-000071EDGAR60K words
2025-08-062025-06-300000886744-25-000052EDGAR
2025-05-072025-03-310000886744-25-000010EDGAR
2024-11-072024-09-300000950170-24-123282EDGAR
2024-08-082024-06-300000950170-24-093950EDGAR
2024-05-022024-03-310000950170-24-052074EDGAR
2023-11-022023-09-300000950170-23-057760EDGAR
2023-08-032023-06-300000950170-23-037931EDGAR
2023-05-112023-03-310000950170-23-020853EDGAR
2022-11-072022-09-300000950170-22-022712EDGAR
2022-08-112022-06-300000950170-22-016839EDGAR
2022-05-092022-03-310000950170-22-008472EDGAR

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-03-260001193125-26-125151EDGAR1K words
2026-02-250001193125-26-068523EDGAR
2026-01-120000886744-26-000003EDGAR
2026-01-060001193125-26-003388EDGAR
2025-12-160000886744-25-000074EDGAR
2025-11-050000886744-25-000068EDGAR
2025-10-140001628280-25-044862EDGAR
2025-08-060000886744-25-000054EDGAR
2025-08-060000886744-25-000048EDGAR
2025-05-270000886744-25-000032EDGAR

349 total filings indexed. 317 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

SXTP — 60 DEGREES PHARMACEUTICALS, INC. ABT — ABBOTT LABORATORIES ABEO — ABEONA THERAPEUTICS INC. ABVC — ABVC BIOPHARMA, INC. ACAD — ACADIA PHARMACEUTICALS INC ACTU — ACTUATE THERAPEUTICS, INC. ADCT — ADC Therapeutics SA ADIL — ADIAL PHARMACEUTICALS, INC.

Company Identity

CIK0000886744
TickerGERN
ExchangeNasdaq
SIC2834: Pharmaceutical Preparations
IncorporatedDE

Get More Data

This is the free public profile. For structured JSON with full provenance chain, use the API:

JSON Profile Stock Quote AI Readiness Report
Origin Provenance
page leaf: 9c5353ff3dd36ad0882ba8b1fdede15cd3e70e5cb124da00925368697a3bb784
parent: 0581abe87615f733c447e073a281ee363d920c3dfed29e60d087ccdd69c7ceb5
content hash: a7dd8facdfc05aa6fae4a870fe5a88bbbd82406b263181838bb7f6657fe66f13
signed: 2026-04-13T04:45:14.866Z
sources: 22 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf